CAMERA, MARINA
 Distribuzione geografica
Continente #
EU - Europa 12.594
NA - Nord America 7.232
AS - Asia 5.219
SA - Sud America 184
AF - Africa 43
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 39
Totale 25.352
Nazione #
US - Stati Uniti d'America 7.070
GB - Regno Unito 4.758
CN - Cina 2.158
IT - Italia 2.073
DE - Germania 1.660
SE - Svezia 1.234
SG - Singapore 1.004
RU - Federazione Russa 773
TR - Turchia 602
KR - Corea 465
IE - Irlanda 448
IN - India 441
UA - Ucraina 338
FR - Francia 299
EU - Europa 284
NL - Olanda 262
FI - Finlandia 252
PL - Polonia 168
ID - Indonesia 153
CA - Canada 149
HK - Hong Kong 126
CO - Colombia 84
DK - Danimarca 68
JP - Giappone 63
BR - Brasile 62
PH - Filippine 59
GR - Grecia 58
VN - Vietnam 53
BE - Belgio 41
AU - Australia 35
AT - Austria 25
ES - Italia 24
RO - Romania 23
CH - Svizzera 22
CL - Cile 22
NO - Norvegia 19
IR - Iran 14
EG - Egitto 13
PK - Pakistan 13
TW - Taiwan 12
CZ - Repubblica Ceca 11
MX - Messico 11
MY - Malesia 10
IL - Israele 9
TH - Thailandia 7
AL - Albania 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
PE - Perù 5
PT - Portogallo 5
RS - Serbia 5
SC - Seychelles 5
ZA - Sudafrica 5
EC - Ecuador 4
IQ - Iraq 4
NG - Nigeria 4
NP - Nepal 4
SA - Arabia Saudita 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CM - Camerun 2
KE - Kenya 2
LV - Lettonia 2
MD - Moldavia 2
ML - Mali 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JO - Giordania 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
MU - Mauritius 1
OM - Oman 1
UG - Uganda 1
Totale 25.598
Città #
Southend 4.513
Chandler 847
Singapore 724
Milan 708
Seattle 647
Princeton 534
Wilmington 492
Dublin 441
Beijing 420
Frankfurt am Main 413
Hanover 365
Ashburn 340
Fairfield 323
Mountain View 309
Redmond 287
Nanjing 245
Santa Clara 244
Dearborn 210
Sakarya 197
Woodbridge 175
Des Moines 168
Ann Arbor 167
Jacksonville 158
Boardman 152
Bengaluru 141
Cambridge 118
Jinan 115
Warsaw 113
Centro 112
Somerville 104
Shenyang 101
Jakarta 96
Andover 91
Houston 89
Seoul 86
Serra 86
Hangzhou 85
Hong Kong 85
Berlin 81
Shanghai 81
Bogotá 80
Changsha 69
Nanchang 68
Bitonto 62
Ottawa 61
Guangzhou 58
Phoenix 58
Tianjin 57
Zhengzhou 57
Hebei 56
Rome 55
Eitensheim 54
Grafing 54
Redwood City 53
Munich 51
Athens 50
Jiaxing 50
Toronto 50
Medford 46
Bühl 40
Helsinki 39
Taizhou 37
Ningbo 36
San Diego 34
Brussels 33
Fuzhou 33
Los Angeles 31
Hamburg 29
Pisa 28
Turin 28
London 27
Padova 27
Istanbul 26
Roxbury 25
Kunming 23
Wuhan 23
Brescia 21
Norwalk 21
Odernheim 21
Lanzhou 20
New York 20
Polska 19
Costa Mesa 18
Chicago 17
Dong Ket 17
Falls Church 17
Central District 16
Haikou 16
Hefei 16
Jeonju 16
Bergamo 15
Bologna 15
Mainz 15
Matsudo 15
Verona 15
Xian 15
Amsterdam 14
Saint Petersburg 14
Vienna 14
Margão 13
Totale 16.671
Nome #
The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease : Insights into Platelet Tissue Factor 401
Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats 297
PCSK9 as a Positive Modulator of Platelet Activation 266
PCSK9 induces a pro-inflammatory response in macrophages 258
MicroRNA-222 Regulates Melanoma Plasticity 235
D-dimer is associated with arterial and venous coronary artery bypass graft occlusion 227
Tissue factor gene promoter haplotype associates with carotid intima-media thickness in subjects in cardiovascular risk prevention 222
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction) : results of a prospective, multicenter study 198
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 190
Lipoproteine aterogene e sintesi di PAI-1 da parte di cellule endoteliali 189
An Intense and Short-Lasting Burst of Neutrophil Activation Differentiates Early Acute Myocardial Infarction from Systemic Inflammatory Syndromes 183
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics : Effects of Improved Dosing Regimens 182
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients : the baseline findings of the MIAMI study 181
Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery 177
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 175
Do methodological differences account for the current controversy on tissue factor expression in platelets? 175
Antithrombotic and anti-inflammatory properties of rosuvastatin in cultured human endothelial cells 174
Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients 174
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL 173
Lipoproteine aterogene e trombosi: aspetti cellulari 172
Biological profile of monocyte-derived macrophages in coronary heart disease patients : implications for plaque morphology 171
Drug repurposing in cardiovascular diseases : Opportunity or hopeless dream? 171
Biochemical and mechanical properties of intraluminal thrombus from human abdominal aortic aneurysm 168
Repurposing of drugs approved for cardiovascular diseases : Opportunity or mirage? 167
A standardized stimulus augment CRP similarly in patients with a history of stable or unstable 166
Synthesis of long-chain polyunsaturated fatty acids is inhibited in vivo in hypercholesterolemic rabbits and in vitro by oxysterols 162
Endothelial Dysfunction in Patients with Severe Mitral Regurgitation 161
Platelet behaviour in patients with drug-eluting stents after thienopyridine treatment discontinuation 160
null 159
Nuove acquisizioni sull'aterosclerosi: placca vulnerabile : relazione su invito 157
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction): Results of a prospective, open-label, multicenter Study. 155
Inflammatory Markers and Carotid Intima Media Thickness (C-IMT) in Stable IHD Patients 155
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 155
The MIAMI study (Markers of Inflammation and Atorvastatin effect in previous Myocardial Infarction): results of a prospective, open-label, multicenter study 148
Vitamin d plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes : a prospective study 145
Vascular thrombogenicity induced by progressive LDL oxidation : protection by antioxidants 143
Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits 143
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study 143
Triglycerides and the fibrinolytic system 141
PCSK9 promotes arterial medial calcification 141
Effetti di Atorvastatina su markers solubili aterosclerosi carotidea : Risultati dello Studio MIAMI 138
E-Selettina e l’inibitore del fattore tissutale (TFPI) correlano con l’inspessimento medio-intimale carotideo (C-IMT) in pazienti con malattia ischemica coronarica in fase di stabilità clinica: risultati basali dello Studio MIAMI 138
Diversity and similarity in signaling events leading to rapid COX-2 synthesis by PMA and TNFin human endothelial cells 138
Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB/IkappaB- and ERK2-dependent mechanisms 138
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process 137
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis 136
Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients 135
Triglycerides and the fibrinolytic system 134
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 134
Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis 134
Proteome of platelets in patients with coronary artery disease 133
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL 132
Tissue factor in patients with acute coronary syndromes : expression in platelets, leukocytes, and platelet-leukocyte aggregates 131
Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up 131
Chemotactic effect of prorenin on human aortic smooth muscle cells : a novel function of the (pro)renin receptor 131
Platelet activation in patients undergoing carotid artery stenting procedure 130
PCSK9 Involvement in Aortic Valve Calcification 130
Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery 129
Nonrheumatic calcific aortic stenosis : an overview from basic science to pharmacological prevention 128
Plasminogen activator inhibitor type-1 mRNA expression is increased by triglyceride rich lipoproteins in human hepatoma cells 127
PLATELET PROTHROMBOTIC AND TRANSCRIPTOMIC PROFILE IN CAD PATIENTS WITH TYPE-2 DIABETES MELLITUS 127
Atherogenic lipoproteins and PAI-1 synthesis by endothelial-cells 127
The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting 125
Expression of alternatively spliced tissue factor in human endothelial cells : induction by inflammatory stimuli and modulation by heparins 124
Soluble E-Selectin and tissue factor pathway inhibitor, but not C-reactive protein, correlate with carotid intima-media thickness (C-IMT) in stable coronary patients: the baseline data of the MIAMI Study 124
Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery 123
Lipoproteine aterogene ed endotelio vascolare 123
Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells 123
Preparazioni piastriniche per studi di trascrittomica: caccia al leucocita 122
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 BY ACETYL-LDL IN HUMAN UMBIUCAL VEIN ENDOTIIELIAL CELLS 122
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon 121
Effetto delle VLDL sull'espressione di mRNA per il PAI-1 in cellule HepG2 121
Comparative transcript profiling of human platelets from patients with stable angina and acute coronary syndromes 120
Titolare di un progetto di Ricerca finanziato dalla Fondazione Italo Monzino dal titolo "Nuovi meccanismi patogenetici delle sindromi coronariche acute: Identificazione dei meccanismi molecolari coinvolti nelle alterazioni del trascrittoma piastrinico osservate nella malattia coronarica 120
Hyperlipidemias and the fibrinolytic system 120
Effect of triglycerides and triglyceride rich lipoproteins on fibrinolytic system 120
Multidetector computed tomography (mdct): able to define the plaque composition as assessed by histology? 119
E-selectin and TFPI are associated with carotid intima-media thickness in stable coronary patients : the baseline findings of the MIAMI Study 118
Effects of triglyceride rich lipoproteins on the synthesis of plasminogen activator inhibitor 1 (PAI-1) by HepG2 cells 118
Triglycerides and the fibrinolytic system: in vitro regulation of the synthesis of plasminogen activator type 1 by triglyceride-rich lipoproteins in HepG2 cells 118
Distinct roles for PAR1 and 2-mediated vasomotor modulation in human arterial and venous conduits used in coronary artery by pass surgery 118
Distinct roles for PAR-1 and PAR-2 mediated vasomotor modulation in human arterial and venous conduits used in coronary artery bypass surgery 117
ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism 117
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation 116
Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome 116
15-deoxy-D12,14-prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. 116
Association of tissue factor A-603G genotype with carotid intima-media thickness in subjects in cardiovascular risk prevention 115
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 115
Carotid versus Coronary Stent Revascularization: Comparison of the Platelet Activation Profile 114
Hypertriglyceridemia and regulation of fibrinolytic activity 114
Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain 114
Platelet behaviour after thienopyridine treatment discontinuation in patients with DES 113
V Congresso monotematico della SIF. Aterotrombosi: dalla ricerca di base alla clinica. Milano, 3-4 Novembre 2011. Organizzazione e segreteria scientifica. 113
Coordinatore di progetto finanziato da Fondazione CARIPLO (2011-0473) "PLATELET ACTIVATION IN TYPE 2 DIABETIC PATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHTS INTO THEIR THROMBOTIC PROPENSITY USING A GENOME-WIDE APPROACH” 113
An increased prothrombotic state lasts up to one month after on-pump and off-pump coronary surgery 113
Inflammatory Markers and C-IMT in Patients with Previous Myocardial Infarction. The Atorvastatin Effect . MIAMI Study 112
Tissue factor mRNA isoforms expression and modulation in lymphomonocytes and platelets of patients with acute coronary syndromes 112
Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus 112
Platelet transcriptome profiling in stable angina and non-ST elevation acute coronary syndrome 112
Eicosanoids and Their Drugs in Cardiovascular Diseases : Focus on Atherosclerosis and Stroke 112
Totale 14.743
Categoria #
all - tutte 84.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.501 0 0 0 0 0 0 317 147 393 410 136 98
2020/20212.802 127 256 221 85 246 235 124 121 316 155 739 177
2021/20223.061 239 118 139 127 243 289 253 205 277 281 373 517
2022/20233.539 551 308 266 397 374 690 106 198 350 52 158 89
2023/20242.290 83 164 140 226 491 164 82 101 65 128 321 325
2024/20252.265 225 540 152 505 525 233 85 0 0 0 0 0
Totale 27.143